Transgene Biotek reports consolidated net loss of Rs 0.07 crore in the September 2024 quarter

Net Loss of Transgene Biotek reported to Rs 0.07 crore in the quarter ended September 2024 as against net loss of Rs 0.13 crore during the previous quarter ended September 2023. Sales rose 20.00% to Rs 0.06 crore in the quarter ended September 2024 as against Rs 0.05 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	0.06	0.05	20
OPM %	-116.67	-240.00	-
PBDT	-0.05	-0.11	55
PBT	-0.07	-0.13	46
NP	-0.07	-0.13	46